Physician profile
Roger Guy Bangs
NPI 1811965049
$2,940.69
in general payments reported to CMS, 2019-2025
5 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.06 · 2022: $162 · 2023: $580 · 2024: $1,113 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,150 · Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,149.95 |
| Food and Beverage | $611.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,648.34 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $171.23 | 2022-2025 | Puraply, Apligraf |
| Smith+Nephew, INC. | $47.50 | 2022-2023 | Renasys Go V2 Home |
| Integra Lifesciences Corporation | $44.20 | 2021-2022 | |
| Abbvie INC. | $29.42 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Bangs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.